Milestone Pharmaceuticals Inc

NASDAQ MIST

Data sourced from iex and EODHD
Download Data

Milestone Pharmaceuticals Inc Income Statement 2018 - 2024

This table shows the Income Statement for Milestone Pharmaceuticals Inc going from 2018 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenue
M 0 -1 0 0 1 4 2 0 0 15 15 15 0 0 0 0 0 0 0 0 0 - - - 0
Cost of Revenue
M 0 1 0 0 0 0 - - - - - - - - - - - - - - 0 - - - 0
Gross Profit
M 0 -1 0 0 1 3 2 - - 15 - 15 - - - - - - - - 0 - - - 0
Operating Expenses
M 11 12 15 16 16 17 17 - - 32 - 14 - - - - - - - - 11 - - - 4
Selling, General, and Administrative Expenses (SG&A)
M 4 3 4 4 4 4 4 4 4 4 3 3 3 2 3 3 3 2 2 2 1 1 1 1 0
Research and Development (R&D) Expenses
M 4 5 7 9 10 11 10 11 9 11 10 9 9 6 8 9 12 14 10 11 8 7 4 3 3
Other Operating Expenses
M 3 4 4 3 2 2 3 - - 17 - 2 - - - - - - - - 2 - - - 1
Costs and Expenses
M 10 13 15 16 16 17 - - - - - - - - - - - - - - 11 - - - 4
Operating Income
M -11 -14 -15 -16 -16 -14 -15 -17 -14 -17 -14 1 -13 -9 -12 -13 -17 -19 -14 -14 -11 -10 -6 -4 -4
Interest Expense
M 1 1 1 1 1 31 0 0 0 0 - 0 0 - 0 0 0 - 1 1 1 - - - 0
Non-operating Income/Expense
M 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0
EBT
M -10 -14 -15 -16 -15 -13 -15 -17 -14 -17 -14 1 -13 -9 -12 -13 -16 -18 -13 -14 -10 -10 -6 -4 -4
Income Tax Provision
M 0 0 1 1 -1 -31 0 0 0 0 - - - 0 0 - 0 0 0 0 0 0 - 0 0
Income after Tax
M -10 -14 -16 -17 -14 18 -14 -16 -14 -17 - - - -9 -12 - -16 -18 -13 -14 -10 -10 - -4 -4
Non-Controlling Interest
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0
Net Income
M - - -15 -16 -15 -13 -15 -17 -14 -17 -14 1 -13 -9 -12 -13 -16 -18 -13 -14 -10 -10 -6 -4 -4
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 50,155,111.00 33,483,111.00 42,973,160.00 42,937,036.00 42,853,275.00 42,780,252.00 42,491,787.00 42,278,563.00 42,243,021.00 42,182,887.00 42,187,887.00 44,530,121.00 41,256,248.00 29,774,065.00 29,774,065.00 24,628,049.00 24,548,777.00 24,548,777.00 24,490,742.00 13,190,638.00 23,147,589.00 23,647,589.00 23,647,589.00 23,647,589.00 23,647,589.00
EBITDA
M -11 -13 -14 -15 -16 -14 -15 -17 -14 -17 -14 1 -13 -9 -12 -13 -17 -19 -14 -14 -11 -10 -6 -4 -4
Depreciation and Amortization
M 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -11 -14 -14 -15 -16 -14 -15 -17 -14 -17 -14 1 -13 -9 -12 -13 -17 -19 -14 -14 -11 -10 -6 -4 -4
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - 0 - - - 0
Tax Rate (Effective)
% 0.65 0.54 -7.43 -7.56 3.69 238.56 3.26 0.95 0.29 -0.20 - - - -0.20 0.14 - 0.01 0.01 0.57 0.03 -0.21 -0.58 - -0.06 -0.38
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% - 161.29 - - 98.20 88.40 100.00 - - 100.00 - 100.00 - - - - - - - - - - - - -
Operating Income Margin
% - 1,598.38 - - -1,550.20 -393.11 -1,002.00 - - -112.79 -95.15 4.75 - - - - - - - - - - - - -
Net Income Margin
% - - - - -1,495.00 -376.49 -970.40 - - -112.56 -94.83 5.13 - - - - - - - - - - - - -
EBITDA Ratio
% - 1,537.09 - - -1,550.20 -393.11 -1,000.20 - - -112.63 -94.99 4.90 - - - - - - - - - - - - -
EBIT Ratio
% - 1,598.38 - - -1,552.00 -393.54 -1,002.00 - - -112.79 -95.15 4.75 - - - - - - - - - - - - -
EBT Ratio
% - 1,576.61 - - -1,495.00 -376.49 -970.40 - - -112.56 -94.83 5.13 - - - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email